IM Cannabis (IMCC) Depreciation & Amortization (CF) (2020 - 2026)
IM Cannabis' (IMCC) quarterly Depreciation & Amortization (CF) came in at $26980.6 in Q1 2026, down 15.84% year-on-year from $32058.2 in Q1 2025, and down 64.5% quarter-over-quarter from $76011.1 in Q4 2025.
IM Cannabis (IMCC) Depreciation & Amortization (CF) (2020 - 2026) Analysis & Trends
IM Cannabis' Depreciation & Amortization (CF) history runs 7 years deep, the most recent figure standing at $26980.6 for Q1 2026.
- On a quarterly basis, Depreciation & Amortization (CF) fell 15.84% year-over-year to $26980.6 in Q1 2026; TTM through Mar 2026 was $223209.5, a 23.24% increase from a year earlier, with the FY2025 full-year figure at $228033.4, down 11.05% from the prior year.
- Depreciation & Amortization (CF) fell to $26980.6 in Q1 2026 per IMCC's latest filing, from $76011.1 in the prior quarter.
- Across five years, Depreciation & Amortization (CF) topped out at $819475.5 in Q1 2022 and bottomed at $13601.1 in Q4 2024.
- The 5-year median for Depreciation & Amortization (CF) is $77703.7 (2024), against an average of $194641.5.
- Across the five-year window, Depreciation & Amortization (CF) sank 84.29% in 2023 and soared 458.86% in 2025, its largest moves.
- Year by year, Depreciation & Amortization (CF) stood at $378665.3 in 2022, then slumped by 80.6% to $73453.6 in 2023, then plunged by 81.48% to $13601.1 in 2024, then surged by 458.86% to $76011.1 in 2025, then tumbled by 64.5% to $26980.6 in 2026.
- Per Business Quant, the three latest IMCC Depreciation & Amortization (CF) figures stand at $26980.6 (Q1 2026), $76011.1 (Q4 2025), and $61037.3 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 239.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 119.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 1.04 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 22.60 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 676.10 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 7.20 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 172.00 Mn |
| 10 | IM Cannabis | 591,792.44 | -193,562.09 | 1.03 Mn | 26,980.61 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 26,980.61 |
| Mar 31, 2026 | 26,980.61 |
| Dec 31, 2025 | 76,011.15 |
| Dec 31, 2025 | 76,011.15 |
| Sep 30, 2025 | 61,037.34 |
| Sep 30, 2025 | 61,037.34 |
| Jun 30, 2025 | 59,180.42 |
| Jun 30, 2025 | 59,180.42 |
| Mar 31, 2025 | 32,058.16 |
| Mar 31, 2025 | 32,058.16 |
| Dec 31, 2024 | 13,601.13 |
| Dec 31, 2024 | 13,601.13 |
| Sep 30, 2024 | 77,703.66 |
| Sep 30, 2024 | 77,703.66 |
| Jun 30, 2024 | 57,760.10 |
| Jun 30, 2024 | 57,760.10 |
| Mar 31, 2024 | 109,090.64 |
| Mar 31, 2024 | 109,090.64 |
| Dec 31, 2023 | 73,453.55 |
| Dec 31, 2023 | 73,453.55 |